Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Yunnan Jinwu Pharmaceutical is a Chinese pharmaceutical firm primarily focused on the research, development, and production of Traditional Chinese Medicines (TCM) for orthopedic and rheumatological conditions. As a key subsidiary of Guizhou Bailing Pharmaceutical Group, the company utilizes a blend of traditional herbal knowledge and modern manufacturing technology. Its most prominent product, the Jinwu Gutong Capsule, is a national-level protected TCM used extensively for the treatment of rheumatoid arthritis, osteoarthritis, and bone hyperplasia. The company's operations are centered in the Yunnan province, leveraging regional biodiversity for its botanical sourcing. Yunnan Jinwu Pharmaceutical maintains a significant market share in the Chinese domestic segment for anti-rheumatic herbal therapies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Yunnan Jinwu Pharmaceutical.